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T he AbioCor imlllantable replacement heart (IRII) is the first available totally implantallle artificial 
lleart and lms been designed as an alternative to trans- 
lllantatiou (ie, destination therapy). Tiffs device Ills 
been ill tile developmental stages by ABIOMED Co. 
Inc. (Dauvers, MA) for over 20 years. Initial preclinical 
trials were conducted at the Texas Heart Institute. The 
1,reclinical trials involving implantation of all comllO- 
nents of the device were performed at botll Texas Iteart 
Institute and the University of Louisville. hi February 
2001, ilerntission to perform clinical trials was granted by 
the Food and Drug Admhfistration (FDA). The clhfieal 
trials were initiated on Jldy 2, 2001, at the University of 
Lotfisville. 
Patients considered for enrolhnent in the trial are 
adult patients witll lliventrieular failure who are not 
eligible for lleart transplantation. All patients mnst 
have a high predicted 30-day mortality based on the 
AbioSeore (• Inc., Danvers, MA) prognostic 
model or ~MI-SHOCK scores. Patients must be depen- 
dent on inotropes or unable to tolerate inotropes be- 
cause of severe arrhytlmfias. Patients are excluded 
from the study if they are believed to be a candidate for 
cardiac transplantation or if they have a significant 
chance of surviving longer tlmu 30 days. Patients are 
also excluded if they had significant end-organ dysflme- 
tion that was believed not to be reversible or lack an 
adequate social support system. All potential candi- 
dates undergo colnputed tomogralllly (CT) scan of the 
chest followed by an AbioFit virtual fit evaluation. The 
AbioFit (ABIOMED hie., Dauvers, MA) evaluation is a 
3 dimensional eomlmterized inmge of the AbioCor su- 
perimposed on tile inmgery of the patient's mediastinal 
and chest wall structures. Tills "virtual surgery" dem- 
onstrates the anatomic relationshii1 of the AbioCor tho- 
racic unit and surrounding structures uch as the pul- 
monary veins and left lower lobe ])ronchus. The 
AbioFit evaluation lnust demonstrate an adequate fit of 
the device before proceeding with operative tllerapy. 
During tllis extensive valuation, tile patient and his 
or her family receive intensive ducation on the device, 
including the results of ilreclinical trials, reliability 
studies, and the results of previous hunmn inlplants. 
Also, all patients are assigned a patient advocate with 
medical background wire is entirely separate from the 
medical team. After obtaining informed consent, we 
proceed with operative intervention. 
Tile AbioCor ilnplantable replacement heart consists 
of both internal and external components. Tile internal 
components are the AllioCor thoracic unit, internal 
battery, controller, anll Transeutaneous Ener~, Transfer 
coil. The internal battery is litlfium ion based and is able 
to power the tlloracic unit for brief (20 to 30 minutes) 
periods of thne. The internal controller controls tile tho- 
racic unit and transnfits dex~ice perfornlance data to a 
lledside cousole through radiofrequency telemetry. The 
iuternal TET coil receives energy transnfitted across the 
skin from the external TET coll. The AbioCor thoracic 
nnit itself consists of 2 pumph~g clmnlbers tllat function as 
the left and right ventricles. Am energy converter is situ- 
ated between tile rigllt and left ventricles tlmt contahls an 
electrically driven centrifugal i ump that provides contin- 
uous hydraulic fluid motion. A switclfing valve deternfines 
tile direction of bydranlic fluid flow, wlfich restdts in 
ahernate left and right systole. All blood contacting sur- 
faces of the AbioCor tlloracic unit inchnling tlie trileaflet 
valves are polyethurethane (An~doflex). The beat rate of 
tile device can be varied between 60 and 150 beats per 
nfinute. Stroke volume is apllroximately 65 mL, and the 
device is therefore able to provide a flow rate 4 to 10 
lnL/min. ~a atrial lmlance elmnd)er is present anll allows 
for decreased right-sided stroke vohnne to maintain right 
and left flui(l balance. Essentially, a portion of hydratdie 
fluid is sllunted into the balance ellanlber ather than to 
tile right l,Umllhlg elmmber. The balance elmmber llas 
effectively llrovided for left to right balance hi all of the 
llreclhfical implants and all of tile clinical hnplants to 
date. 
External eoml,ollents consist of an external TET coil, 
external batteries, and external patient-carried elec- 
tronics. The external TET coil transfers energy from 
batteries or a standard wall outlet across the skin to tlle 
internal TET coil. The Imtient-carried electronics con- 
tains basic alarm systems similar to left ventricular 
assist device. 
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1/~ An infraclavicular inci- 
sion is made approximately 8.0 to 
9.0 cm in length and placed ap- 
proximately 2.0 em cephalad to 
tile nipple. This can be l~erformed 
oil either tile left or right side. 
Tile position is often dictated by 
tile bandedness of the patient or 
the presence of a previously 
placed pacemaker or internal car- 
diae difibrillator. A pocket for the 
internal TET coil is made directly 
over the pectoral fascia. Tiffs po- 
sition of the internal TET coil will 
allow for the external and inter- 
nal TET coils to be close enough 
to allow energy transfer. Median 
sternotomy incision is then per- 
formed. The internal TET coil is 
placed in the pocket and the TET 
cable is tunnelc,l over the ribs 
and brought out through tile 
lower portion of the sternotomy 
incision. The incision over the in- 
ternal TET coil is closed in 2 lay- 
ers before heparinization i an at- 
tempt to decrease the likelihood 
of hematoma formation. Any fluid 
or llematoma round the internal 
TET  coil couhl interfere with en- 
ergy transfer. 
1 ] l~  The 4 internal compo- 
nents of the AbioCor implantable 
replacement heart. The AbioCor 
thoracic unit is positioned in an 
orthotolfiC position after excision 
of the native ventricles. The inter- 
nal TET coil is placed hi tile hffra- 
clavicular space directly over the 
pectoral fascia. Tile internal bat- 
tery and internal controller are 
placed in tile abdominal wall. 
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2 Sternal retractor is placed in tile chest, and a pericardial cradle is created. Dissection is made in tile preperitoneal space 
for placement of tile internal controller and an internal battery. In severely cachectic patients, the battery and controller may 
be placed anterior to the posterior sheath of the rectus fascia to avoid entry into the peritoneal cavity. Intravenous heparin 
is administered. Depending on the length of the aorta, the distal ascending aorta or the femoral artery may be caunulated for 
arterial inflow. A right angle cannula is placed in the superior vena cava, and a long femoral vein cannula is placed through 
tile femoral vein and positioned just below the right atrium using manual palpation to verify appropriate position. No cannulas 
are placed in the right atrium in an attempt o avoid any sites that would allow for air to be entrained into the right atrium 
during normal fimction of the AbioCor thoracic unit. Caval tapes are placed around the SVC and inferior vena cava. The cable 
from the internal controller is passed off tile operative fiehl to the external controller. 
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3 Cardiopuhnonary bypass is initiated. Tile caval tapes are snared dox~aa. Tile aorta is cross-clamped. Lidocaine is injected 
directly into the proxhnal aorta to provide rapid diastolic arrest of tile heart (not sho~al). Be~nning oll the right side of the heart, 
the ventricles are excised on the ventricnlar side of the atrioventricular groove, leaving the nfitral and tricuspid annula intact. The 
great vessels are transeeted at the orion. The ventricles are further trimmed to leave a small rhn of ventrieular muscle in place. The 
nfitral and tricuspid valve leaflets are excised. Inspection is then nmde for a patent foramen ovale, and if that is present, it should 
be closed at this time. The left atrial appendage is ligated. The coronary sinus is oversex~aa to prevent any venous hleeding from cut 
branches of draining veins. 
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Ll  A left atrial Milar catheter is placed through tile right superior puhnonary vein. Tile left atrial cuff is trimmed to 
api,rol,riate size and sewn to tile native left annulus using a running 4-0 Prolene suture. A second layer of 4-0 Prolene is used 
with the suture being placed over a second layer of felt strip that is placed directly on top of the anastomosis to reinforce the 
anastomosis. The 2 reinforced suture layers are designed to prevent 1,oth bleeding and entrainment of air. 
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5 Tile left atrial anastomosis  checked for leaks using an inflated Foley catheter to occlude 
tile puhnonary veins while injecting saline into tile left atrium. A similar procedure is then used 
to anastomose the right atrial cuff to the native right atrial remnant. This is usually done at the 
level of the annulus but nmy be performed irectly to the right atrium if the right atrium is 
excessively arge. Ahernatively, the right atrium nmy be plicated to decrease its size and allow for 
the atrial cuff to be anastomosed at the level of the annulus. The right atrial anastomosis  also 
tested for leaks by forcefully injecting saline into the right atrium as was performed on the left. 
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6 Tile AbioCor dulmny heart is passed up to tile operative fiehl anti attached to the left and 
right atrial cuffs. This allows for determination of the length and orientation of the right and left 
outflow grafts. Tile lmlmonary artery outflow graft is then trimmed to an appropriate l ngth and 
sewn end-to-end to the puhnonary artery using running 4-0 Prolene. This graft will likely be quite 
short. The anastomosis i tested for hemostasis. Similarly, tile outflow graft to tile aorta is 
trimmed to appropriate l ngth and sewn end-to-end to the aorta. This is also tested for hemostasis 
by putting a plug on the proxinml end and temporarily removing the aortic cross-clamp. 
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~' /~ Tile AbioCor thoracic unit is brought up to tile ol)erative fiehl. 
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7B  Tile cables from tile TET coil and thoracic unit are connected to tile internal controller. Tile AbioCor is placed into 
the pericardial space. 
7~1~ The left atrial quick connect is performed first followed by tile aortic quick connect and the pulmonary artery quick 
connect. Initially, tile right atrial quick connect is not attached. 
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A bulb syringe is used to inject 
saline into the right ventricle of the 
AbioCor to facilitate de-airing. 
When the air in the right ventricle is 
minimized, the eaval tapes are re- 
leased with partial occlusion of the 
venous return to facilitate filling of 
the right atrium, and the right atrial 
quick connect is performed. One or 
two single injections of the AbioCor 
are then performed to ensure that 
the connections are adequate. The 
SVC tubing is clamped, and the SVC 
cannula is removed. This site is over- 
sewn to allow for hemostasis and 
aerostasis. 
~y 
9 \Vhile tile cross-clamp remains on tile 
aorta, de-airing is performed by allowing tile 
AbioCor to beat at all increasing rate and pro- 
gressively higher stroke volumes. The blood is 
ejected through side ports on both the 1)ulmo- 
nary artery and aortic outflow conduits. 
t' '1 
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10 Wbeo the right ventricle is completely de-aired, tile side port of tile puhnonary 
artery outflow conduit is clampcd, and complete de-airing of tile left side of tile 
AbioCor is l)crformed while alloxdng tile entire stroke volume to bc ejected out tile 
aortic side port. One can very easily manipulate the AbioCor to assist in complete 
de-airing, and one can visualize the entire vcntricles to ensure that there is no 
residual air in the device. Typically, we allow tile AbioCor to beat at a rate of 60 to 
80 beats per minute with a fllll stroke volume. Once we are convinced, based on 
echocardiograplly of the atria and inspection of the AbioCor, that de-airing is 
complete, we allow for 1 or 2 more minutes of this de-airing procedure. 
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11 After complete de-airing, tile aortic et-oss-claml~ is released, and simuhaneously tile 
outflow side port of tile aortic outflow graft is clamped. Tile patient is rapidly weaned from 
cardiolmlmonary bylmss onto fidl AbioCor support over a 1- or 2-minute time period. Tile 
patient is on fidl AbioCor support with continuous monitoring of left anti right atrial pressures. 
Manual palpation of the right atrium is eontinuonsly performed to help determine appropriate 
fluid administration and AbioCor beat rate. An imlmlance between the left anti right-sided filling 
pressures i corrected by making apl,ropriate adjustments to the atrial balance chamber. If left 
and right filling pressures are both low, this is treated by volume administration. If they are both 
high, the beat rate of the AbioCor device is increased. After surgical hemostasis i obtained, 
protamine is administered and decannulation is performed. A sterile bag is placed over the 
external TET coil, which is I, laced over the internal TET coil. The internal battery is passed up 
to the operative fiehl, connected to the controller, and placed in the right preperitoncal space. At 
this point, the patient is relying entirely on the internal components with transcutancous energy 
transfer. Echocardiography is crucial at this point to determine whether there are normal 
velocities in the puhnonary veins, particnlarly the left-sided puhnonary veins. 
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12 Tile sternum is al~l~roximated using 2 or 3 towel clips, and puhnonary flow velocities are 
re-assessed. If there is ally increase of flow ill the lmlmonary veins, the AbioCor can be tacked 
caudad by placing a stitch around either tile right ventrieular outflow tract or through one of the 
islets. The suture is then placed around the lowest rib, and the suture is tied. The sternum is 
again aplwoximated to demonstrate nornml puhnonary vein llow velocities. Al~propriate chest 
tubes are placed. 
